Neural progenitor cell populations
AssigneeGeron Corporation
InventorMelissa Carpenter
Life of this patent
Estimating the term…
Abstract
This invention provides populations of neural progenitor cells, differentiated neurons, glial cells, and astrocytes. The populations are obtained by culturing stem cell populations (such as embryonic stem cells) in a cocktail of growth conditions that initiates differentiation, and establishes the neural progenitor population. The progenitors can be further differentiated in culture into a variety of different neural phenotypes, including dopaminergic neurons. The differentiated cell populations or the neural progenitors can be generated in large quantities for use in drug screening and the treatment of neurological disorders.
Claims30
A cell population that proliferates in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, wherein at least ˜30% of the cells in the population are committed to form neuronal cells, glial cells, or both.
A cell population that proliferates in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, comprising at least ˜60% neural progenitor cells, wherein at least 10% of the cells can differentiate into neuronal cells, and at least 10% of the cells can differentiate into glial cells.
A cell population that proliferates in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, comprising at least ˜60% neural progenitor cells, wherein at least 10% of the cells express A2B5, and at least 10% of the cells express NCAM.
A cell population comprising at least ˜60% neural progenitor cells and/or mature neurons that have the same genome as an established human embryonic stem (hES) cell line.
A method for obtaining neural precursor cells capable of producing a cell population comprising at least 1% tyrosine hydroxylase positive cells, comprising differentiating human embryonic stem cells.
A method for obtaining a cell population comprising at least 1% tyrosine hydroxylase positive cells, comprising differentiating human embryonic stem cells.
Dependencies are inferred from the claim text.